American Heart Association issues statement on cardiovascular side effects from hormonal therapy for prostate cancer

The American Heart Association issued a statement addressing cardiovascular risks from hormonal therapy for prostate cancer, emphasizing the need to identify men with pre-existing cardiac risk factors or a family history of cardiovascular diseases who should be monitored closely during treatment.